Chronic Myeloid Leukaemia Developing During Long-Term Alectinib Therapy Successfully Managed With Concomitant Nilotinib: A Case Report. [PDF]
Ikematsu Y +3 more
europepmc +1 more source
Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by optical genome mapping and targeted NGS. [PDF]
Navas Acosta J +25 more
europepmc +1 more source
Complementary efficacy of CD127-directed immunotherapy with lusvertikimab and ABL-targeting tyrosine kinase inhibitors in preclinical ABL-class-fusion-positive B-ALL. [PDF]
Pinkle D +35 more
europepmc +1 more source
Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review. [PDF]
Harada Y +15 more
europepmc +1 more source
Real world lessons on tyrosine kinase inhibitor response and resistance in CML from a developing country Pakistan. [PDF]
Khan S +3 more
europepmc +1 more source
Two novel e13a3 variants detected in CML patients and their DNA breakpoint analysis. [PDF]
Liang D +6 more
europepmc +1 more source
Pharmacological SOS1 inhibitor BI-3406 synergizes with BCR::ABL1 TKIs reducing leukemia stem cells and overcoming imatinib resistance in CML. [PDF]
García-Navas R +16 more
europepmc +1 more source
Ru-Based Photocaged Kinase Inhibitors Operative under Deep-Red Light Irradiation. [PDF]
Pragti +5 more
europepmc +1 more source
Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway. [PDF]
Yin C +8 more
europepmc +1 more source
Treatment response and survival outcomes with BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a retrospective study. [PDF]
Liu Y, Zhang L, Zeng L.
europepmc +1 more source

